Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112461 · ClinicalTrials.gov registry record · NA
Hospice and End-of-life Symptom Monitoring & Support Using an Automated System Designed for Family Caregivers
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 365
- Enrollment target
NCT02112461: Completed NA study, sponsored by University of Utah.
NCT02112461 is a NA study that has completed, run by University of Utah. The registered enrollment target is 365 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02112461, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 365 participants
- Enrollment target
Study Summary
Improving end-of-life care and the suffering caused by poorly controlled symptoms is an important public health concern. The development of an automated telephone symptom monitoring and support system that assists caregivers in providing end-of-life care and communicating information to the patient's hospice nurse has the potential to enhance the management of common end of life symptoms, thus reducing the suffering of patients at end of life as well as the suffering of their family caregivers. This study has developed such a system and is testing the effectiveness of this system.
Primary Outcome
Caregiver's report their assessment of the severity of patient's symptoms daily.
Interventions
- BEHAVIORAL SCP-Hospice Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2010-05 |
| Est. Completion | 2017-04 |
| Phase | NA |
What the finished NCT02112461 record still lists
NCT02112461 is an interventional study that assigns participants to a tested intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 1 intervention - of which SCP-Hospice Alert is the first listed.
NCT02112461 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02112461 about?
NCT02112461 is a clinical study titled "Hospice and End-of-life Symptom Monitoring & Support Using an Automated System Designed for Family Caregivers". Improving end-of-life care and the suffering caused by poorly controlled symptoms is an important public health concern. The development of an automated telephone symptom monitoring and support system that assists caregivers in providing end-of-life care and communicating information to the patient'...
What is the current status of trial NCT02112461?
This trial is currently completed. It is a NA study. The enrollment target is 365 participants. The study started on 2010-05. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02112461?
The interventions under investigation include: SCP-Hospice Alert (BEHAVIORAL).
Who is sponsoring clinical trial NCT02112461?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02112461's enrollment target sits among peer trials
365 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia